Arterial density increases as fibrosis advances, affecting disease outcomes. Tissue hypoxia and angiogenic factors like VEGF and transforming growth factor-β further drive disease progression, ...

Objectives Anti-Ro52 autoantibodies are associated with more severe interstitial lung disease (ILD) in adult myositis patients with antiaminoacyl transfer (t)RNA synthetase autoantibodies. However, ...

Pulmonary fibrosis can develop following a lung injury, including COVID-19, but most cases arise without any clear cause. Once diagnosed, the disease rapidly damages the lung, and patients usually ...

Chronic obstructive pulmonary disease (COPD) is a group of progressive lung diseases that obstruct airflow. You may experience breathing difficulties, but you can treat and even prevent flare-ups.

If you live with a chronic or autoimmune disease ... after having a tattoo on her thigh. It was her second tattoo, the first being completed some years earlier without incident. A lung transplant ...

Sionna Therapeutics is eyeing a $156 million IPO as the cystic-fibrosis-focused biotech looks to take its lead candidate into phase 2. The Waltham, Massachusetts-based company already unveiled ...

Background Lung function testing remains a cornerstone in the assessment and management of interstitial lung disease ... were white individuals. Idiopathic pulmonary fibrosis (IPF), connective tissue ...

Background Fibrotic interstitial lung diseases (fILDs ... To ensure the presence of clinically meaningful fibrosis, patients will be required to have CT evidence of pulmonary fibrosis (ie, traction ...

1 Among them, anti-MDA5 presented with a a greater risk with interstitial lung disease (ILD), which may lead to poor prognosis. In clinical practice, some patients are refractory to immunosuppressive ...

3. Cystic fibrosis. National Organization for Rare Disorders. Accessed January 5, 2022. 4. Cystic fibrosis. Centers for Disease Control and Prevention. Accessed January 5, 2022. 5. Chen Q, Shen Y, ...